Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease

Glioma is a highly proliferative and aggressive tumor type that arises from glial cells in the central nervous system. The nucleotides required for the proliferation and replication of glioma cells are crucial to their pathogenesis and often cannot be synthesized entirely de novo by tumor cells. These nucleotides must be taken up from the extracellular milieu to achieve the purpose of proliferation, a process that is mediated by solute carriers in the SLC28, SLC29, and SLC43 families. The expression of these solute carriers is linked to the proliferation of glioma cells, indicating their key role in glioma metabolism. Understanding the mechanisms underlying nucleotide transport and metabolism in gliomas may lead to the development of novel therapeutics that target these metabolic pathways and improve the prognosis for patients with glioma. Solute carrier family SLC28-, SLC29-, and SLC43-mediated nucleotide transport is involved in the proliferation of glioma and plays an important role in the proliferation and invasion of glioma. Among them, SLC43A3 is a potential biomarker for glioma proliferation, and the data presented here provide evidence for solute carrier involvement in glioma metabolism and construct a prognostic model.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Deletion of equilibrative nucleoside transporter 2 disturbs energy metabolism and exacerbates disease progression in an experimental model of Huntington's disease

Cited by 3 publications

References 43 publications

A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer’s Disease

A Comprehensive Review of Membrane Transporters and MicroRNA Regulation in Alzheimer’s Disease

Equilibrative nucleoside transporter 3 supports microglial functions and protects against the progression of Huntington’s disease in the mouse model

Preliminary Analysis of Solute Carrier Family in Nucleotide Rescue Synthesis in Glioma

Contact Info

Product

Resources

About